Pharmacological treatment of schizophrenia

Psychiatry

Volumn 4, Issue 11, 2005, Pages 36-39

  Kerwin, Robert ^a   Osborne, Sarah ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

antipsychotics; aripiprazole; clozapine; olanzapine; risperidone; schizophrenia

Indexed keywords

EID: 52449098583     PISSN: 14761793     EISSN: None     Source Type: Journal    
DOI: 10.1383/psyt.2005.4.11.36     Document Type: Article

References (6)

1. Bolonna A.A., and Kerwin R.W. Partial agonism and schizophrenia. Br J Psychiatry 186 (2005) 7-10
2. In: Dollery C. (Ed). Therapeutic drugs. 2nd Edition (1998), Churchill Livingstone, Edinburgh
3. In: Morgan G., and Butler S. (Eds). Seminars in basic neurosciences (1993), Gaskell, London
4. National Institute for Clinical Excellence. Guidance on the use of newer (atypical) antipsychotic drugs for the treatment of schizophrenia. Technology Appraisal Guidance No. 43 (2002), NICE, London
5. Nicholls J.G., Martin A.R., and Wallace B.G. From neuron to brain: a cellular and molecular approach to the function of the nervous system. 3rd ed. (1992), Sinauer, Sunderland, MA
6. In: Taylor D., McConnell D., McConnell H., Abel K., and Kerwin R. (Eds). The Maudsley Prescribing Guidelines. 6th ed. (2001), Martin Dunitz, London